Search
for
Sort by
Research 781–810 of 1000+
- Janus kinase inhibitors for alopecia areata: A narrative review
- Increased risk of alopecia areata in patients with autism spectrum disorders: A Korean nationwide population-based study
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Role of 8-Hydroxydeoxyguanosine in Patients with Alopecia Areata
- Dermoscopic Analysis of Patients with and without Poor Prognostic Indicators in Alopecia Areata – A Comparative Study
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- New Modalities in the Treatment of Refractory Alopecia Areata
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Life Events Preceding Alopecia Areata Onset—a Descriptive Retrospective Cohort Study Focusing on Strain
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.
- Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial
- Bare Realities: Uncovering the Life‑Altering Impacts of Alopecia Areata
- Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- The Effectiveness and Safety of Three Treatment Regimens of Topical Minoxidil 5.0%, Betamethasone 0.064% w/w, and Castor and Jojoba Oils for Alopecia Areata: A Multicenter Cohort Study
- Immunohistochemical assessment of SOX10 and its relation to the immune cellular infiltrate in alopecia areata follicles
- The role of hsa‐miR‐193a‐5p as an important factor for control of inositol in alopecia areata
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study